TCTC Holdings’s Avanos Medical AVNS Stock Holding History

TCTC Holdings’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-75	Closed	-$1.8K	–	716
2024 Q3	$1.8K	Hold	75	–	–	﹤0.01%	493
2024 Q2	$1.49K	Hold	75	–	–	﹤0.01%	506
2024 Q1	$1.49K	Hold	75	–	–	﹤0.01%	515
2023 Q4	$1.68K	Hold	75	–	–	﹤0.01%	480
2023 Q3	$1.52K	Hold	75	–	–	﹤0.01%	428
2023 Q2	$1.92K	Sell	75 -119	-61%	-$3.13K	﹤0.01%	410
2023 Q1	$5.77K	Buy	194 +29	+18%	+$842	﹤0.01%	420
2022 Q4	$4.46K	Hold	165	–	–	﹤0.01%	393
2022 Q3	$4K	Hold	165	–	–	﹤0.01%	384
2022 Q2	$5K	Hold	165	–	–	﹤0.01%	371
2022 Q1	$6K	Sell	165 -4	-2%	-$129	﹤0.01%	369
2021 Q4	$6K	Hold	169	–	–	﹤0.01%	403
2021 Q3	$5K	Hold	169	–	–	﹤0.01%	419
2021 Q2	$6K	Hold	169	–	–	﹤0.01%	372
2021 Q1	$7K	Hold	169	–	–	﹤0.01%	367
2020 Q4	$8K	Sell	169 -150	-47%	-$6.24K	﹤0.01%	355
2020 Q3	$11K	Hold	319	–	–	﹤0.01%	332
2020 Q2	$9K	Buy	+319	New	+$9.23K	﹤0.01%	334

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

TCTC Holdings's AVNS Position: Q4 2024 in Review

TCTC Holdings sold out of Avanos Medical (AVNS) in Q4 2024, closing a stake of 75 shares — an estimated $1.8K sold.

TCTC Holdings first reported a position in AVNS in Q2 2020 and held it in 18 quarters. The position peaked at $11K in Q3 2020. 258 funds tracked by Wall St. Rank hold AVNS as of Q4 2024.

TCTC Holdings reported no remaining Avanos Medical position as of Q4 2024 after selling out during the quarter.
TCTC Holdings sold 75 Avanos Medical shares in Q4 2024, an estimated $1.8K.
TCTC Holdings first reported a position in Avanos Medical in Q2 2020 and held it in 18 quarters.
TCTC Holdings's Avanos Medical position peaked at $11K in Q3 2020.
258 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2024.

Based on TCTC Holdings's 13F filing for Q4 2024, filed 10 Feb 2025.